Pancreatic Cancer Research

ResearcherDalian Medical UniversityActive in the last 2 years

Deshi Dong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3266-4314; OpenAlex author ID A5010863857. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 8

  1. Lipid Nanoparticle-Based αHTRA1 mRNA Improves Pancreatic Ductal Adenocarcinoma Redox Microenvironment by Suppressing HTRA1/HIF-1 Signaling. Last author DOI 10.1021/acs.bioconjchem.6c00013↗
  2. Peptides in the Diagnosis and Treatment of Pancreatic Cancer and Other Pancreatic Diseases from Basic Research to Clinical Translation. Co-author DOI 10.2147/dddt.s610190↗
  3. Targeted drug delivery systems for pancreatic cancer therapy: advances, challenges, and future perspectives. Last author DOI 10.3389/fimmu.2026.1785625↗
  4. Targeted mitochondrial therapy for pancreatic cancer. Co-author DOI 10.1016/j.tranon.2025.102340↗
  5. Carfilzomib relieves pancreatitis-initiated pancreatic ductal adenocarcinoma by inhibiting high-temperature requirement protein A1. Co-author DOI 10.1038/s41420-024-01806-w↗
  6. Metabolic reprogramming of immune cells in pancreatic cancer progression. Co-author DOI 10.1016/j.biopha.2022.113992↗
  7. Advances in targeted therapy for pancreatic cancer. Last author DOI 10.1016/j.biopha.2023.115717↗
  8. S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives. Last author DOI 10.3389/fonc.2021.711180↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xufeng Tao · 8 shared papers, 2021–2026 · strength 2.05
  2. Xiaonan Zhang · 3 shared papers, 2026 · strength 0.96
  3. Fangyue Guo · 3 shared papers, 2021–2026 · strength 0.71
  4. Guangshuo Gan · 2 shared papers, 2026 · strength 0.65
  5. Xinya Zhao · 2 shared papers, 2025–2026 · strength 0.64
  6. Hong Xiang · 3 shared papers, 2023–2024 · strength 0.60
  7. Jing Liu · 1 shared paper, 2025 · strength 0.33
  8. Xu Yao · 1 shared paper, 2026 · strength 0.32
  9. Yu Wu · 1 shared paper, 2024 · strength 0.24
  10. Dong Shang · 1 shared paper, 2024 · strength 0.24
  11. Lin Xing · 1 shared paper, 2023 · strength 0.18
  12. Qi Zhou · 1 shared paper, 2021 · strength 0.16
  13. Yu Wu · 1 shared paper, 2021 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.